NRSNNeuroSense Therapeutics Ltd.

NRSN Stock Price, Valuation & Chart | NeuroSense Therapeutics Ltd.

Compare

$0.420+0.00 (+1.14%)

At close · 02 Sept 2026, 07:59 pm

Sector: Healthcare Industry: Biotechnology NRSN intrinsic value NRSN calculated fair value vs price

Overview Financials Dividends Ratios

NRSN Historical price chart

NRSN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization15.02M

PE Ratio-0.83

EPS-0.51

Trading Volume211.36K

Today's High/Low0.45/0.39

Dividend Yield0.00

52 Week High/Low1.98/0.25

Shares Outstanding35.35M

NRSN Financial Statement

NRSN Analyst ratings

NRSN Analysis & performance metrics

NRSN Company profile

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating…

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes…

NRSN Management team

Name

Position

Hagit Binder

Chief Operation Officer

Niva Russek-Blum Ph.D.CTO

Chief Technology Officer

Yael Barak

Vice President of Quality & Compliance

Alon Ben-NoonCEO

Co-Founder, Chief Executive Officer & Director

Or EisenbergCFO

Chief Financial Officer

Ferenc Tracik M.D.

Chief Medical Officer

Keren Pushett

Head of HR

Name

Position

Hagit Binder

Chief Operation Officer

Niva Russek-Blum Ph.D.CTO

Chief Technology Officer

Yael Barak

Vice President of Quality & Compliance

Alon Ben-NoonCEO

Co-Founder, Chief Executive Officer & Director

Or EisenbergCFO

Chief Financial Officer

Ferenc Tracik M.D.

Chief Medical Officer

Keren Pushett

Head of HR

Management Team

Hagit Binder

Chief Operation Officer

Niva Russek-Blum Ph.D.CTO

Chief Technology Officer

Yael Barak

Vice President of Quality & Compliance

Alon Ben-NoonCEO

Co-Founder, Chief Executive Officer & Director

Or EisenbergCFO

Chief Financial Officer

Ferenc Tracik M.D.

Chief Medical Officer

Keren Pushett

Head of HR

Management

Hagit Binder

Chief Operation Officer

Niva Russek-Blum Ph.D.CTO

Chief Technology Officer

Yael Barak

Vice President of Quality & Compliance

Alon Ben-NoonCEO

Co-Founder, Chief Executive Officer & Director

Or EisenbergCFO

Chief Financial Officer

Ferenc Tracik M.D.

Chief Medical Officer

Keren Pushett

Head of HR

Total 7 executives

NRSN Frequently asked questions

What is NeuroSense Therapeutics Ltd. (NRSN) Stock Price?

Current stock price of NeuroSense Therapeutics Ltd. (NRSN) stock is $0.420. The stock price is +1.14% higher in the session. The intraday range can be seen from this page. Volume of NeuroSense Therapeutics Ltd. (NRSN) stock is 211.36K.

Last updated at 02 Sept 2026, 07:59 pm.

Why is the NeuroSense Therapeutics Ltd. (NRSN) stock price going up or down today?

The stock price of NeuroSense Therapeutics Ltd. (NRSN) can change with earnings, company news, and overall market sentiment. NeuroSense Therapeutics Ltd. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the NeuroSense Therapeutics Ltd. stock expensive at its current price?

Whether NeuroSense Therapeutics Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NRSN on this page is -0.83. EPS on this page is -0.51. Compare those figures with peers and growth expectations before deciding if the current NeuroSense Therapeutics Ltd. price is justified.

How has the stock price of NeuroSense Therapeutics Ltd. (NRSN) performed historically?

Historical performance for NeuroSense Therapeutics Ltd. (NRSN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NRSN reacted to past earnings and market events.

Should I buy NeuroSense Therapeutics Ltd. (NRSN) stock, at this price?

Buying NeuroSense Therapeutics Ltd. (NRSN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.